Assessment of the treatment costs of extracorporeal shock wave therapy versus surgical treatment for shoulder diseases.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 11758305)

Published in Int J Technol Assess Health Care on January 01, 2001

Authors

M Haake1, M Rautmann, T Wirth

Author Affiliations

1: Phillips University Marburg.

Articles by these authors

(truncated to the top 100)

A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64

An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (1987) 4.11

NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96

High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48

Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36

Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28

A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet (1996) 2.16

Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science (1997) 1.93

Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem (2001) 1.92

Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood (2000) 1.79

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56

Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54

[Colonic stenting: an opportunity with a risk : A critical evaluation]. Chirurg (2015) 1.38

Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci U S A (2000) 1.36

Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35

Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut (2005) 1.34

Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (MuRRS). Nucleic Acids Res (1985) 1.33

Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J (1994) 1.30

Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J Biol Chem (1999) 1.27

Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood (1998) 1.25

Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci U S A (2001) 1.24

Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J (2001) 1.23

Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol (1993) 1.19

Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood (2001) 1.15

The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res (1994) 1.13

Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1. J Biol Chem (1995) 1.10

Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev (1995) 1.06

Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res (2001) 1.05

Evidence for mobility of a new family of mouse middle repetitive DNA elements (LTR-IS). Nucleic Acids Res (1984) 1.03

Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol (2004) 1.02

Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene (1995) 1.02

Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01

A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res (1991) 1.01

CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01

Mitochondrial differentiation in a polymorphic land snail: evidence for Pleistocene survival within the boundaries of permafrost. J Evol Biol (2003) 1.01

Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther (2006) 1.00

Model for estimating enteric methane emissions from United States dairy and feedlot cattle. J Anim Sci (2008) 1.00

Failures and complications in intramedullary nailing of children's forearm fractures. J Child Orthop (2010) 0.99

The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98

Treatment of severely displaced proximal humeral fractures in children with retrograde elastic stable intramedullary nailing. Injury (2008) 0.98

Evidence that a major class of mouse endogenous long terminal repeats (LTRs) resulted from recombination between exogenous retroviral LTRs and similar LTR-like elements (LTR-IS). Proc Natl Acad Sci U S A (1984) 0.97

The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells. Eur J Immunol (2000) 0.96

NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev (2000) 0.96

Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther (2003) 0.96

[Treatment of congenital clubfoot with the Ponseti method]. Z Orthop Ihre Grenzgeb (2006) 0.95

Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J (1994) 0.95

CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93

Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol (2008) 0.92

Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression. Am J Med Genet (1999) 0.92

Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. Histol Histopathol (2005) 0.91

Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J Biol Chem (1993) 0.90

Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res (1994) 0.89

Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther (2006) 0.89

Induction of nuclear factor-kappa B during primary B cell differentiation. J Immunol (1998) 0.87

Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice. Nucleic Acids Res (1992) 0.86

Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene (2012) 0.85

Isolation and characterization of microsatellite loci in the yellow perch (Perca flavescens), and cross- species amplification within the family Percidae. Mol Ecol (2000) 0.85

VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Gene Ther (2009) 0.84

[Treatment of vertical talus with the Dobbs method]. Z Orthop Unfall (2011) 0.83

Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood (2001) 0.83

Arthroscopic reduction of the dislocated hip in infants. J Bone Joint Surg Br (2012) 0.83

Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res (1991) 0.82

[Wound secretions in standard orthopedic surgery interventions using a new kind of closed vacuum drainage. A report of experiences]. Unfallchirurg (1991) 0.82

The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene (2010) 0.81

No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats. Eur J Pharmacol (1998) 0.80

The influence of intermittent external dynamic pressure and tension forces on the healing of an epiphyseal fracture. Arch Orthop Trauma Surg (2001) 0.80

Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy. Cancer Gene Ther (2012) 0.80

Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein. Gene Ther (2003) 0.80

Glutamate-dependent activation of NF-kappaB during mouse cerebellum development. J Neurosci (1997) 0.80

Novel polymer-bound chiral selenium electrophiles. Org Lett (2001) 0.79

[Diagnosis and therapy of coxitis fugax with special reference to the value of ultrasonographY-assisted diagnosis and hip joint puncture]. Z Orthop Ihre Grenzgeb (1993) 0.79

Demethylation and the establishment of kappa allelic exclusion. Cold Spring Harb Symp Quant Biol (1999) 0.79

[Mid-term results of idiopathic clubfeet treated with the Ponseti method]. Z Orthop Unfall (2012) 0.79

Identification of target genes of the lymphoid-specific transcription factor Oct2. Immunobiology (1997) 0.79

RelB is a key player for both kappa B-dependent transcription and demethylation in B cells. Immunobiology (1997) 0.79

In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Ther (1999) 0.78

[Predicting the outcome of diskectomy.]. Schmerz (1991) 0.78

Genetic signatures in an invasive parasite of Anguilla anguilla correlate with differential stock management. J Fish Biol (2010) 0.78

Molecular genetics of the germinal center reaction. J Cell Physiol (1998) 0.78

The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation. J Biol Chem (1998) 0.77

Isolation and characterization of 12 dinucleotide microsatellites in the European eel, Anguilla anguilla L., and tests of amplification in other species of eels. Mol Ecol Resour (2008) 0.77

Analysis of promoter activity by polymerase chain reaction amplification of reporter gene mRNA. Anal Biochem (1996) 0.77

ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. Leukemia (2008) 0.77

[Minimally invasive treatment of congenital foot deformities in infants: new findings and midterm-results]. Orthopade (2013) 0.76

Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somat Cell Mol Genet (1996) 0.76

Controversies in childhood osteosarcoma. Minerva Pediatr (2013) 0.76

Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression. J Cancer Res Clin Oncol (2005) 0.76

[Is conservative treatment of partial or complete anterior cruciate ligament rupture still justified? An analysis of the recent literature and a recommendation for arriving at a decision]. Z Orthop Ihre Grenzgeb (1992) 0.76

[Elastic stable intramedullary nailing as alternative therapy for the management of paediatric humeral shaft fractures]. Z Orthop Unfall (2009) 0.76

[Coxitis fugax--the beginning of Perthes' disease?]. Z Orthop Ihre Grenzgeb (2006) 0.75

[The effect of asbestos cement, UICC asbestos samples and quartz on the peritoneum of the mouse]. Pathol Microbiol (Basel) (1975) 0.75

False-positive sonographic hip examinations in newborns with congenital varus deformity of the proximal femur. Arch Orthop Trauma Surg (1995) 0.75

[Participation refusal by probands in an epidemiologic long-term study--sociodemographic, clinical and psychometric findings]. Psychother Psychosom Med Psychol (1992) 0.75

ICPD perspectives: institutional views. U.S., other countries increase efforts. Netw Res Triangle Park N C (1995) 0.75

[Psychometric assessment of defense mechanisms: correlation between questionnaire and expert rating. Initial study of validity]. Psychother Psychosom Med Psychol (1993) 0.75

[An update on thrombosis prophylaxis in orthopaedic and accident surgery]. Orthopade (2004) 0.75

[Contribution to the study of medullary lines in reptiles: the granulocytic, lymphocytic and monocytic lines]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.75

[Results of ACL reconstruction with a periost-patella tendon-periost graft in growth age]. Z Orthop Unfall (2007) 0.75

[Multi-dimensional evaluation of pain perception and its importance for the behavior of patients with chronic low back pain.]. Schmerz (1991) 0.75

Application of differential cDNA screening techniques to the identification of unique gene expression in tumours and lymphocytes. Curr Opin Immunol (1998) 0.75